Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
T., McConnell, A
Some studies suggest an association, while others do not show a clear increased risk
2 The management of obesity continues to evolve with the approval of new treatments
This double-blind, placebo-controlled trial randomized (1:1) adults with body mass index 30 or 27 kg/m 2 and at least one obesity-related complication (excluding diabetes), who achieved 5.0% weight reduction after a 12-week intensive lifestyle intervention, to tirzepatide maximum tolerated dose (10 or 15 mg) or placebo once weekly for 72 weeks ( n = 579)
This includes regular follow-up, dose adjustments, and clinical monitoring
US$ 23.30
US$ 20.58
US$ 21.51
US$ 26.49
US$ 22.93
US$ 20.25
US$ 27.82
